These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6684595)

  • 21. Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
    Santos NA; Catão CS; Martins NM; Curti C; Bianchi ML; Santos AC
    Arch Toxicol; 2007 Jul; 81(7):495-504. PubMed ID: 17216432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cisplatin on renal function in rabbits: mechanism of reduced glucose reabsorption.
    Kim YK; Byun HS; Kim YH; Woo JS; Lee SH
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):19-26. PubMed ID: 7839366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin C attenuates cisplatin-induced alterations in renal brush border membrane enzymes and phosphate transport.
    Fatima S; Arivarasu NA; Mahmood R
    Hum Exp Toxicol; 2007 May; 26(5):419-26. PubMed ID: 17623766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity.
    Campbell AB; Kalman SM; Jacobs C
    Cancer Treat Rep; 1983 Feb; 67(2):169-72. PubMed ID: 6681731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Covalent binding of platinum to renal protein from sensitive and resistant guinea pigs treated with cisplatin: possible role in nephrotoxicity.
    Litterst CL; Schweitzer VG
    Res Commun Chem Pathol Pharmacol; 1988 Jul; 61(1):35-48. PubMed ID: 3175342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyst formation in rat kidney induced by cis-platinum administration.
    Dobyan DC; Hill D; Lewis T; Bulger RE
    Lab Invest; 1981 Sep; 45(3):260-8. PubMed ID: 7196972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uptake enhancement of platinum in the dog kidney by microencapsulation of cisplatin and local injection.
    Hecquet B; Depadt G; Fournier C; Meynadier J
    Anticancer Res; 1986; 6(1):65-9. PubMed ID: 3954334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury.
    Wondergem J; Bulger RE; Strebel FR; Newman RA; Travis EL; Stephens LC; Bull JM
    Cancer Res; 1988 Jan; 48(2):440-6. PubMed ID: 3335012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increase in serum uric acid level associated with cisplatin therapy. Correlation with liver but not kidney platinum concentrations.
    Nanji AA; Mikhael NZ; Stewart DJ
    Arch Intern Med; 1985 Nov; 145(11):2013-4. PubMed ID: 4062451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity.
    Hanigan MH; Gallagher BC; Taylor PT; Large MK
    Cancer Res; 1994 Nov; 54(22):5925-9. PubMed ID: 7954424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prophylactic effect of methylprednisolone on cisplatin-induced nephrotoxicity].
    Koikawa Y
    Fukuoka Igaku Zasshi; 1995 Feb; 86(2):31-9. PubMed ID: 7729781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on adequate intervals of cisplatin administration to ameliorate cisplatin-induced nephrotoxicity].
    Sakatoku H; Kawai K; Kamiya H; Sakurai M
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):239-46. PubMed ID: 3947105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats.
    Esposito M; Vannozzi M; Viale M; Pellecchia C; Civalleri D; Gogioso L
    Anticancer Res; 1995; 15(6B):2541-7. PubMed ID: 8669820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amelioration of cisplatin-induced ototoxicity by fosfomycin.
    Schweitzer VG; Dolan DF; Abrams GE; Davidson T; Snyder R
    Laryngoscope; 1986 Sep; 96(9 Pt 1):948-58. PubMed ID: 3747696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system.
    Stöhr W; Paulides M; Bielack S; Jürgens H; Koscielniak E; Rossi R; Langer T; Beck JD
    Pediatr Blood Cancer; 2007 Feb; 48(2):140-7. PubMed ID: 16724313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal handling of cisplatin: interactions with organic anions and cations in the dog.
    Klein J; Bentur Y; Cheung D; Moselhy G; Koren G
    Clin Invest Med; 1991 Oct; 14(5):388-94. PubMed ID: 1742916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The renal fractional clearance of platinum antitumour compounds in relation to nephrotoxicity.
    Daley-Yates PT; McBrien DC
    Biochem Pharmacol; 1985 May; 34(9):1423-8. PubMed ID: 4039567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of renal excretion of cisdichlorodiamine platinum.
    Caterson R; Etheredge S; Snitch P; Duggin G
    Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):255-64. PubMed ID: 6685336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hexachloro-1:3-butadiene-induced renal tubular necrosis in the mouse.
    Ishmael J; Pratt I; Lock EA
    J Pathol; 1984 Mar; 142(3):195-203. PubMed ID: 6707786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.